Andrew S. Boyer
CIK: 0001239546
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Amneal Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Sep 1, 2026AMRX
Amneal Pharmaceuticals, Inc.
Gift(G)Direct80K shares- - Aug 21, 2026AMRX
Amneal Pharmaceuticals, Inc.
Gift(G)Direct152.4K shares- - Mar 4, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct19.1K shares at avg. $13.30$255K - Mar 4, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct38.2K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct199.2K shares at avg. $13.31$2.7M - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct39.3K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct19.9K shares at avg. $13.31$265K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct49.7K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct24.9K shares at avg. $13.31$331K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct24.3K shares- - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct12.2K shares at avg. $13.31$162K - Mar 3, 2026AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct397.6K shares- - Mar 2, 2026AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
65.4K shares- - Mar 2, 2026AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectPerformance-Based Restricted Stock Units
65.4K shares- - Aug 20, 2025AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct175K shares at avg. $2.75$481K - Aug 20, 2025AMRX
Amneal Pharmaceuticals, Inc.
Sale(S)Direct279.2K shares at avg. $9.38$2.6M - Aug 12, 2025AMRX
Amneal Pharmaceuticals, Inc.
Sale(S)Direct33.4K shares at avg. $9.05$303K - Mar 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
Sale(S)Direct125K shares at avg. $8.89$1.1M - Mar 4, 2025AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct38.2K shares- - Mar 4, 2025AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct19.5K shares at avg. $8.84$173K - Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct25.4K shares at avg. $8.76$223K - Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct157K shares- - Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
Tax Payment(F)Direct80.3K shares at avg. $8.76$704K - Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
97K shares- - Mar 3, 2025AMRX
Amneal Pharmaceuticals, Inc.
Exercise(M)Direct39.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Gift(G) | 80,000 | - | $0 | Direct |
| Aug 21, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Gift(G) | 152,426 | - | $0 | Direct |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 19,136 | $13.30 | $254,509 | Direct |
| Mar 4, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 38,195 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 199,175 | $13.31 | $2,651,019 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 39,252 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 19,945 | $13.31 | $265,468 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 49,694 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 24,897 | $13.31 | $331,379 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 24,258 | - | $0 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 12,154 | $13.31 | $161,770 | Direct |
| Mar 3, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 397,554 | - | $0 | Direct |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 65,359 | - | - | Direct |
| Mar 2, 2026 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Performance-Based Restricted Stock Units | 65,359 | - | - | Direct |
| Aug 20, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 175,000 | $2.75 | $481,250 | Direct |
| Aug 20, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Sale(S) | 279,244 | $9.38 | $2,619,309 | Direct |
| Aug 12, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Sale(S) | 33,436 | $9.05 | $302,596 | Direct |
| Mar 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Sale(S) | 125,000 | $8.89 | $1,111,250 | Direct |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 38,194 | - | - | Direct |
| Mar 4, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 19,537 | $8.84 | $172,707 | Direct |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 25,419 | $8.76 | $222,670 | Direct |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 157,005 | - | - | Direct |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Tax Payment(F) | 80,309 | $8.76 | $703,507 | Direct |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 97,032 | - | - | Direct |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Exercise(M) | 39,251 | - | - | Direct |
1-25 of 30 transactions
About BOYER ANDREW S
BOYER ANDREW S (SEC CIK 0001239546) files insider reports with the SEC as Executive Vice President of Amneal Pharmaceuticals, Inc. (AMRX).
Signal8 holds 9 ownership filings by BOYER ANDREW S, all Form 4s, filed between Mar 4, 2025 and Sep 2, 2026. Those filings report 30 transactions, from Mar 1, 2025 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BOYER ANDREW S's filings is in BRIDGEWATER, NJ.
Recent filings by BOYER ANDREW S
Other insiders filing for Amneal Pharmaceuticals, Inc. (AMRX)
- BUCHI J KEVIN, Director
- Kiely John, Director
- Shah Nikita, Executive Vice President
- Daly Jason B., EVP, Chief Legal Officer
- Patel Tushar Bhikhubhai, 10% Owner
- Patel Chintu, Co-CEO